1. Home
  2. CSBR vs PTMN Comparison

CSBR vs PTMN Comparison

Compare CSBR & PTMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • PTMN
  • Stock Information
  • Founded
  • CSBR 1985
  • PTMN 2006
  • Country
  • CSBR United States
  • PTMN United States
  • Employees
  • CSBR N/A
  • PTMN N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • PTMN Finance: Consumer Services
  • Sector
  • CSBR Health Care
  • PTMN Finance
  • Exchange
  • CSBR Nasdaq
  • PTMN Nasdaq
  • Market Cap
  • CSBR 151.0M
  • PTMN 152.6M
  • IPO Year
  • CSBR 1986
  • PTMN N/A
  • Fundamental
  • Price
  • CSBR $10.17
  • PTMN $17.40
  • Analyst Decision
  • CSBR Strong Buy
  • PTMN Hold
  • Analyst Count
  • CSBR 1
  • PTMN 3
  • Target Price
  • CSBR $8.00
  • PTMN $19.33
  • AVG Volume (30 Days)
  • CSBR 46.1K
  • PTMN 37.7K
  • Earning Date
  • CSBR 03-11-2025
  • PTMN 03-13-2025
  • Dividend Yield
  • CSBR N/A
  • PTMN 15.86%
  • EPS Growth
  • CSBR N/A
  • PTMN N/A
  • EPS
  • CSBR N/A
  • PTMN 0.39
  • Revenue
  • CSBR $53,571,000.00
  • PTMN $65,828,000.00
  • Revenue This Year
  • CSBR $14.19
  • PTMN N/A
  • Revenue Next Year
  • CSBR $10.11
  • PTMN N/A
  • P/E Ratio
  • CSBR N/A
  • PTMN $45.10
  • Revenue Growth
  • CSBR 7.19
  • PTMN N/A
  • 52 Week Low
  • CSBR $3.60
  • PTMN $15.94
  • 52 Week High
  • CSBR $11.99
  • PTMN $20.84
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 48.12
  • PTMN 66.49
  • Support Level
  • CSBR $10.32
  • PTMN $17.20
  • Resistance Level
  • CSBR $11.33
  • PTMN $17.41
  • Average True Range (ATR)
  • CSBR 0.99
  • PTMN 0.23
  • MACD
  • CSBR -0.20
  • PTMN 0.02
  • Stochastic Oscillator
  • CSBR 29.57
  • PTMN 84.18

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About PTMN Portman Ridge Finance Corporation

Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.

Share on Social Networks: